PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9099794

Antibody engineering.

M S Hayden·L K Gilliland·J A Ledbetter
View original source ↗Export metadata ↓

Abstract

The development of recombinant techniques for the rapid cloning, expression, and characterization of cDNAs encoding antibody (Ab) subunits has revolutionized the field of antibody engineering. By fusion to heterologous protein domains, chain shuffling, and inclusion of self-assembly motifs, novel molecules such as bispecific Abs can now be generated which possess the subset of functional properties designed to fit the intended application. Rapid technological developments in phage display of peptides and proteins have led to a plethora of applications directed towards immunology and antibody engineering. Many of the problems associated with the therapeutic use of Abs are being addressed by the application of these new techniques.

Explore related subjects

Genetic EngineeringHumansImmunoglobulinsJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M S Hayden, L K Gilliland, J A Ledbetter. 1997. Antibody engineering.. https://doi.org/10.1016/s0952-7915(97)80136-7

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Reverse genetics of influenza virus.

Reverse genetics of negative-sense RNA viruses, which enables one to generate virus entirely from cloned cDNA, has progressed rapidly over the past decade. However, despite the relative ease with which nonsegmented negative-sense RNA viruses can now be produced from plasmids, the ability to generate viruses with segmented genomes has lagged considerably, largely because of the inherent technical difficulties in providing all viral RNAs and proteins from cloned cDNA. A breakthrough in reverse genetics technology in the influenza virus field came in 1999, when we (Neumann et al., 1999, Proc. Natl. Acad. Sci. USA 96, 9345-9350) and others (Fodor et al., 1999, J. Virol. 73, 9679-9682) exploited a new approach to viral RNA production. In this review, we discuss the background for this advance, the systems that are now available for the generation of influenza viruses, and the implications of these developments for the future of virus research.

Genetic Engineering↗
PubMed2001

Engineering disease resistance in plants.

Ever since the initial discovery of the molecules and genes involved in disease resistance in plants, attempts have been made to engineer durable disease resistance in economically important crop plants. Unfortunately, many of these attempts have failed, owing to the complexity of disease-resistance signalling and the sheer diversity of infection mechanisms that different pathogens use. Although disease-resistant transgenic plants or seeds are not yet available commercially, future product development seems likely as our current level of understanding of pathogenesis and plant defence improves.

Genetic Engineering↗